Near-patient bilirubin testing to enable neonatal care at home

Tender description

This Pre-commercial Procurement (PCP)/ Small Business Research Initiative (SBRI) competition, which will fund Phase 1 feasibility studies with R&D contracts in the region of 60,000 GBP, inclusive of VAT. This is a Small Business Research Initiative (SBRI)/Pre-commercial Procurement competition funded by the Scottish Government Chief Scientists Office (CSO), the Scottish Government Directorate for Children and Families and the Royal Hospital for Children, Glasgow and Glasgow Children's Hospital Charity. The aim of this competition is to provide an opportunity for organisations working in partnership with NHS Scotland, to develop disruptive innovative solutions. These solutions will focus on near-patient bilirubin testing to develop innovative care pathways and enable family centred care at home for babies who do not require to be in hospital. NO COMMERCIAL CONTRACT CAN BE AWARDED AS A RESULT OF THIS R&D PROCUREMENT, AND PURCHASE OF ANY OUTPUT REQUIRES A SEPARATE CONTRACTING PROCESS WHICH MAY BE ADVERTISED SEPARATELY. To obtain additional documents please register your interest in this notice and download from the additional documentation section. Applications are to be submitted through the notice Postbox. it is advised that applications are submitted well in advance of the deadline date and time to allow for any technical issues to be resolved. Technical support on Public Contracts Scotland (PCS) can be accessed by PCS Helpline: 0800 222 9003. Contracts will be between NHS Golden Jubilee and winning participants. Phase 1 is allocated 60,000 GPB inclusive of VAT for a maximum of 4 projects. Phase 1 projects can range in size up to a total cost of 15,000 GPB inclusive of VAT. The open innovation challenge provides an opportunity for organisations, working in partnership with NHS Scotland Innovation Hubs to develop disruptive innovative solutions that focus on the monitoring of jaundiced newborns at home. These solutions will focus on near-patient bilirubin testing to develop innovative care pathways and enable family centred care at home for babies who do not require to be in hospital. Innovative solutions are sought for near-patient bilirubin monitoring of newborns which are accurate, efficient, safe, accessible and equitable. These solutions will enable the development of innovative care pathways. Solutions must be working towards compliance with UKAS accredited point of care testing (POCT) (ISO15189:2022) methodology for analysis. When fully developed, solutions must include a real-time process to incorporate results into NHS Scotland electronic patient records. Phase 1: Technical feasibility studies This means planned research or critical investigation to gain new knowledge and skills for developing new products, processes or services. There is a potential Phase 2 planned with the expectation that 2 contracts are awarded, chosen from the successful phase 1 applicants, to develop a prototype and undertake field testing for up to 12 months. The total budget for phase 2 is 160,000 GPB. Phase 2 projects can range in size up to total costs of 80,000 GPB inclusive of VAT. At this stage contracts will be given for phase 1 only. SHIP reserves the right not to award any contracts. SHIP are not committed to proceeding to Phase 2 whether or not the previous phases were successful. SHIP gives no guarantee or warranty as to the nature, or number of projects funded. To lead a project, you can: - be any type of organisation of any size, registered in the UK, European Union (EU) and the European Economic Area (EEA) that can demonstrate a credible and practical route to market - work alone or with others from business, research organisations, research and technology organisations or the third sector as subcontractors. Contracts will be given to successful applicants. Contract terms and conditions are accessible as an additional document to this notice; "SBRI_ Authority Contract V7 Scotland - CLO 2 - FINAL" Under current restrictions, this competition will not fund any procurement, commercial, business development or supply chain activity with any Russian and Belarusian entity as lead, partner or subcontractor. This includes any goods or services originating from a Russian and Belarusian source. Briefing Event 25th October 2023 10:00-12:00 UK Time. Event registration: https://book.shsc.scot/shsc/frontend/reg/thome.csp?pageID=206690&eventID=560&traceRedir=2 Any adoption and implementation of a solution from this competition would be the subject of a separate, possibly competitive, procurement exercise. This competition covers R&D not the purchase of any solution. Please do not contact the NHS Scotland Innovation Hubs direct. If you have any questions relating to NHS Scotland Innovation Hubs available resources, please direct your question to the Q&A portal on PCS before 11am UK time on 6th December 2023 or at the Q&A session during the Briefing Event on 25th October 2023 10:00 – 12:00 UK time.